Effects of Angiotensin-Receptor Blockade With Olmesartan on Carotid Atherosclerosis in Patients With Hypertension: The Confirmatory Olmesartan Plaque Regression Study.
Phase of Trial: Phase IV
Latest Information Update: 25 Jun 2018
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Atenolol
- Indications Hypertension
- Focus Pharmacodynamics
- Acronyms CONFIRM
- Sponsors Daiichi Sankyo Inc
- 30 Mar 2012 Actual patient number is 114 according to ClinicalTrials.gov.
- 22 Feb 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 22 Feb 2012 Planned end date changed from 1 Jun 2012 to 1 Dec 2012 as reported by European Clinical Trials Database.